IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Remus Pharmaceuticals IPO offer price is ₹ 1229.00 and got listed at ₹ 1711.00. Read IPO details mentioned above.
Remus Pharmaceuticals IPO listing price is ₹ 1711.00, issue price is ₹ 1229.00, and currently trading at ₹ 2020.40 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Remus Pharmaceuticals IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Beeline Capital Advisors is the merchant banker of Remus Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 10th March 2023.
Remus Pharmaceuticals IPO offer price is ₹ 1229.00 and got listed at ₹ 1711.00. Read Infraprime Logistics Technologies IPO details mentioned above.Remus Pharmaceuticals IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Marketing and distribution pharmaceutical drugs. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Remus Pharmaceuticals IPO size is ₹ 47.69 Cr. with fresh issue size of ₹ 47.69 Cr. and Offer for sale being Nil
The IPO allotment date for Remus Pharmaceuticals IPO is expected to be 24th May 2023, after the finalization of basis of allotment. Investors can check Remus Pharmaceuticals IPO allotment status on the registrars website, Link Intime India Private Limited. Remus Pharmaceuticals IPO refund dates are 25th May 2023.
Remus Pharmaceuticals IPO is expected to be listed on 29th May 2023.
The upper price band for the Remus Pharmaceuticals IPO is set at ₹ 1229.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Remus Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Remus Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 19th May 2023. After submission, funds are blocked until the basis of allotment of Remus Pharmaceuticals IPO is finalised.
The merchant banker for Remus Pharmaceuticals IPO is Beeline Capital Advisors Private Limited . Beeline Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Remus Pharmaceuticals IPO RHP for further details.
The registrar for Remus Pharmaceuticals IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Remus Pharmaceuticals IPO through their official website or helpline.
Remus Pharmaceuticals IPO was subscribed 57.21 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:Remus Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Remus Pharmaceuticals Financial Review Page
Merchant Banker(s) of Remus Pharmaceuticals IPO: Beeline Capital Advisors Private Limited
Remus Pharmaceuticals IPO subscription was 57.21 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Remus Pharmaceuticals IPO listed at a listing price of 1711.00 against the offer price of 1229.00.
The current market price of Remus Pharmaceuticals is 2020.40.
Why Us?
